Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Giving kids with CF a chance at a longer, healthier life

COMBAT CF is one of two long-standing international trials which have resulted in new early intervention options helping to reduce progressive lung damage in kids living with CF.

DCD a heavy burden for little Toby

Meet Toby - he has developmental coordination disorder (DCD), a neurodevelopmental condition that causes delays and impairments in fine and gross motor skills.

More than a good night's sleep: why a preterm baby's body clock may unlock the secret to life-long health

A simple set of eye masks and ear plugs – an inexpensive solution explored in a successful pilot study by The Kids Research Institute Australia, together with the Child and Adolescent Health Service – could hold the key to better outcomes for our tiniest bubs. Now, a nationwide clinical trial is testing the idea

Campaign designed to improve the lung health of Aboriginal children

A public health campaign to raise awareness about the dangers of chronic wet cough in Aboriginal children is helping to improve detection, diagnosis and management of the condition.

EYI helps community spotlight dental health

Communities in the Central Great Southern region have known for years that dental health is a major issue for the smallest residents of their towns.

Early support helps Stirling thrive

Amy Bertinshaw had a choice between ‘wait and see’ or seek help when she noticed her son Stirling was slower to meet developmental milestones at age 12 months.

New treatments on horizon for rarest child brain cancers

The WA Kids Cancer Centre has a suite of world-leading research projects to unlock new treatments for childhood cancers.

Research

Just what the doctor ordered: moving forward with electronic health records

To provide dietitians with information on the proposed introduction of electronic medical records in Australia and New Zealand and discuss potential benefits...

Research

Predominance of nontypeable haemophilus influenzae in children with otitis media

In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.

Research

Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance

Concerns about the risk of inducing immune deviation-associated "neonatal tolerance" as described in mice have restricted the widespread adoption...